Dr. XUAN Linli is currently Chief of Medical Oncology at Jiahui International Cancer Center (JICC). With over 30 years of experience in cancer research and clinical practice, Dr. XUAN possesses extensive expertise in diagnosis and treatment of hematologic and oncologic illness, including cancer risk assessment and reduction.

 
After 6 years of study in Shanghai Medical University, Dr. XUAN furthered her clinical training in the Hematology Division of the Internal Medicine Department at Huashan Hospital Fudan University, under the guidance of Professor DING Xunjie, one of the founding figures of the Hematology Department at Huashan Hospital and a key authority in hematology nationwide. Then in the US, she spent an additional 6 years in residency and fellowship training, including specialization in medical oncology and hematology at the University Hospitals, Case Western Reserve University in Cleveland Ohio. Before joining Jiahui Health, Dr. XUAN practiced medical oncology and hematology in the U.S. for over two decades. She obtained certifications from the American Board of Internal Medicine (ABIM) in Internal Medicine, Medical Oncology, and Hematology. Dr. XUAN is also a member of the American Society of Clinical Oncology (ASCO).

 
With a solid academic foundation, systematic training in both China and the U.S., and years of clinical experience in patient care, Dr. XUAN is well-versed in internationally advanced technologies for cancer prevention, diagnosis, and treatment. She is skilled in managing a variety of oncological and hematological diseases. She is detail-oriented and excels in communication with patients and their families. She firmly believes that cancer treatment planning should involve collaboration between patients, families and other disciplines. Additionally, she prioritizes patients' quality of life and is adept at alleviating suffering through standardized, internationally recognized personalized treatment plans and symptom management.

 
Dr. XUAN’s areas of expertise in hematology and oncology treatment include but not limited to:
-Diagnosis and treatment of solid tumors, particularly all stages of breast cancer, advanced gynecological malignancies, advanced prostate cancer and other urological cancer, colorectal cancer, esophageal and stomach cancer, lung cancer, skin cancers especially melanoma, etc.
-Diagnosis and treatment of hematologic malignancies, especially multiple myeloma and lymphoma, chronic lymphocytic leukemia, myeloproliferative neoplasms.
-Diagnosis and treatment of other hematologic conditions, including anticoagulation therapy, platelet disorder, myelodysplastic syndromes and all causes of anemia.
-Cancer genetics, including cancer risk assessment and risk reduction,
-Palliative care, including pain management and supportive therapy.